Education
About Us
Working with TipRanks
Follow Us
Neuronetics (STIM)
:STIM
Earnings Data
Report Date
Aug 12, 2025Before Open (Confirmed)
Period Ending
2025 (Q2)Consensus EPS Forecast
-0.08Last Year’s EPS
-0.33Same Quarter Last Year
Moderate Buy
Based on 1 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Neutral
The earnings call highlighted robust revenue growth driven by the Greenbrook acquisition and successful execution of strategic initiatives such as the BMP program and SPRAVATO rollout. However, challenges were noted in terms of decreased gross margin, increased operating expenses, and a widened net loss. Despite these challenges, the company remains on track to achieve cash flow positivity by the third quarter.Company Guidance -
Q1 2025
Significant Revenue Growth
Total revenue was $32 million, an increase of 84% over the first quarter of 2024. On a pro forma basis, total revenue increased 7% over pro forma revenue of $29.8 million for the first quarter of 2024.
Successful Greenbrook Integration
The integration of Greenbrook has been effective, with 95% of identified synergies realized by the end of 2024, and expectations to exceed $23 million in total realized synergies.
SPRAVATO Rollout Progress
SPRAVATO is now offered in 75 of the 95 Greenbrook clinics, up from 35 clinics at the beginning of the quarter, with Buy & Bill treatments generating approximately 3x the revenue compared to the administer and observe model.
Expansion of BMP Program
The BMP program includes over 385 active sites, with sites in the program treating three times more patients per site per quarter than non-participating practices.
Adolescent Treatment Growth
The number of adolescent patients receiving treatment grew by 38% in the first quarter of 2025 compared to the first quarter of 2024.
STIM Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
STIM Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
May 06, 2025 | $4.50 | $4.50 | 0.00% |
Mar 04, 2025 | $4.26 | $5.06 | +18.78% |
Nov 12, 2024 | $1.10 | $0.69 | -37.27% |
Aug 12, 2024 | $1.78 | $0.74 | -58.43% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Neuronetics (STIM) report earnings?
Neuronetics (STIM) is schdueled to report earning on Aug 12, 2025, Before Open (Confirmed).
What is Neuronetics (STIM) earnings time?
Neuronetics (STIM) earnings time is at Aug 12, 2025, Before Open (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is STIM EPS forecast?
STIM EPS forecast for the fiscal quarter 2025 (Q2) is -0.08.